Ken Griffin UNITY BIOTECHNOLOGY INC Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025
Number of Shares
42,300
Previous 38,900 8.74%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
N/A
-2,998 Reduced 4.15%
69,210 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-21,383 Reduced 22.85%
72,208 $0
Q1 2024

May 15, 2024
BUY
N/A
44,915 Added 92.27%
93,591 $0
Q4 2023

Feb 14, 2024
BUY
N/A
48,676 New
48,676 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-920 Reduced 35.48%
1,673 $0
Q1 2023

May 15, 2023
SELL
N/A
-31,527 Reduced 92.4%
2,593 $0
Q4 2022

Feb 14, 2023
BUY
N/A
34,120 New
34,120 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email